MENU
+Compare
UTHR
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$284.09
Change
-$0.00 (-0.00%)
Capitalization
12.82B

UTHR United Therapeutics Corp Forecast, Technical & Fundamental Analysis

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs... Show more

UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for UTHR with price predictions
Jun 27, 2025

Aroon Indicator for UTHR shows an upward move is likely

UTHR's Aroon Indicator triggered a bullish signal on June 09, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 258 similar instances where the Aroon Indicator showed a similar pattern. In of the 258 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where UTHR's RSI Oscillator exited the oversold zone, of 21 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 51 cases where UTHR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

UTHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on UTHR as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for UTHR turned negative on June 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

UTHR moved below its 50-day moving average on June 10, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for UTHR crossed bearishly below the 50-day moving average on June 17, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UTHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.884) is normal, around the industry mean (16.366). P/E Ratio (11.324) is within average values for comparable stocks, (58.189). Projected Growth (PEG Ratio) (0.734) is also within normal values, averaging (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (4.579) is also within normal values, averaging (252.247).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. UTHR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

UTHR is expected to report earnings to rise 10.26% to $7.31 per share on July 30

United Therapeutics Corp UTHR Stock Earnings Reports
Q2'25
Est.
$7.31
Q1'25
Beat
by $0.10
Q4'24
Missed
by $0.49
Q3'24
Missed
by $0.14
Q2'24
Missed
by $0.63
The last earnings report on April 30 showed earnings per share of $6.63, beating the estimate of $6.53. With 215.00 shares outstanding, the current market capitalization sits at 12.82B.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1168
Web
https://www.unither.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NFLP41.950.16
+0.38%
Kurv Yield Premium Str Netflix ETF
DMAR39.470.06
+0.14%
FT Vest US Equity Deep Bffr ETF Mar
SIXS46.800.03
+0.07%
ETC 6 Meridian Small Cap Equity ETF
EWW60.320.01
+0.02%
iShares MSCI Mexico ETF
EFFI22.15N/A
N/A
Harbor Osmosis International Resource Efficient ETF

UTHR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, UTHR has been loosely correlated with DAWN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if UTHR jumps, then DAWN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
N/A
DAWN - UTHR
38%
Loosely correlated
-0.15%
MNKD - UTHR
38%
Loosely correlated
-0.27%
GERN - UTHR
36%
Loosely correlated
-3.27%
CERO - UTHR
33%
Poorly correlated
-14.66%
UNCY - UTHR
32%
Poorly correlated
+14.48%
More

Groups containing UTHR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
N/A
Pharmaceuticals
category (298 stocks)
27%
Poorly correlated
-0.04%